Last $56.41 USD
Change Today +0.60 / 1.07%
Volume 49.3K
ICLR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 9:51 AM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

icon plc (ICLR) Snapshot

Open
$55.99
Previous Close
$55.81
Day High
$56.46
Day Low
$55.83
52 Week High
09/17/14 - $56.36
52 Week Low
04/30/14 - $35.33
Market Cap
3.5B
Average Volume 10 Days
523.6K
EPS TTM
$2.25
Shares Outstanding
61.6M
EX-Date
--
P/E TM
25.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for ICON PLC (ICLR)

icon plc (ICLR) Related Businessweek News

No Related Businessweek News Found

icon plc (ICLR) Details

ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, Rest of Europe, the United States, and internationally. It specializes in the development, management, and analysis of programs that support various stages of the clinical development process-from compound selection to Phase I-IV clinical studies. The company also offers clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics, and laboratory services. Its clinical research services include investigator recruitment, study monitoring and data collection, case report form preparation, statistical analysis, patient safety monitoring, clinical data management, interactive voice response technologies, electronic patient reported outcomes, medical reporting, patient registries, outcomes research, health economics, and marker access and commercialization services. The company’s clinical research services also comprise strategic analysis and data operation, clinical pharmacology, bioanalysis, immunoassay development, pharmacokinetic and pharmacodynamic analysis, study protocol preparation, regulatory consulting, product development planning, strategic consulting, pricing and market access consulting, medical imaging, contract staffing, and electronic endpoint adjudication, sample analyses, safety testing, microbiology, custom flow cytometry, electronic transmission of test results, and biomarker development services. ICON Public Limited Company was founded in 1990 and is headquartered in Dublin, Ireland.

11,000 Employees
Last Reported Date: 08/14/14
Founded in 1990

icon plc (ICLR) Top Compensated Officers

Chief Executive Officer, Director and Chairma...
Total Annual Compensation: €1.8M
Chief Financial Officer and Member of Executi...
Total Annual Compensation: €664.0K
Chief Operating Officer
Total Annual Compensation: €934.0K
Compensation as of Fiscal Year 2013.

icon plc (ICLR) Key Developments

ICON Plc Appoints Ira Spector as Executive Vice President, Analytics and Consulting

ICON plc has appointed Ira Spector as executive vice president, analytics and consulting. In this role, Dr. Spector will lead ICON's global consulting and drug development services and will also be responsible for ICON's business process improvement and analytics capabilities. Dr. Spector is an expert in clinical development and brings to ICON over 25 years of experience in managing global drug and medical device development programmes. He joins ICON from Allergan Pharmaceuticals, where he was Senior vice president of Global Development Operations.

Icon plc Announces Consolidated Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Revises Earnings Guidance for the Full Year of 2014

ICON plc announced consolidated unaudited earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net revenues of $376,020,000 compared with $334,219,000 for the same period a year ago. Income from operations was $48,288,000 compared with $26,299,000 for the same period a year ago. Income before provision for income taxes was $48,250,000 compared with $26,199,000 for the same period a year ago. Net income was $40,783,000 or $0.64 per diluted share compared with $22,479,000 or $0.36 per diluted share for the same period a year ago. For the six months, the company reported net revenues of $725,654,000 compared with $651,008,000 for the same period a year ago. Income from operations was $91,286,000 compared with $49,295,000 for the same period a year ago. Income before provision for income taxes was $91,339,000 compared with $49,010,000 for the same period a year ago. Net income was $76,978,000 or $1.22 per diluted share compared with $41,524,000 or $0.67 per diluted share for the same period a year ago. Guidance for the full year 2014 has been updated with EPS guidance increased from a range of $2.30 - $2.40 to a range of $2.62 - $2.68 and revenue narrowed to a range of $1.490 billion - $1.530 billion. The company’s revenue guidance implies that it will exit 2014 with operating margin towards the upper end of existing target margin range of 12% to 14%. So beyond 2014, the company is now targeting operating margins in the region of 14% to 16%.

ICON Public Mulls Acquisitions

ICON Public Limited Company (NasdaqGS:ICLR) intends to pursue acquisitions."So it's really just making sure that you continue at scale. And we are saying we are going to continue to do that nice bolt-on acquisition strategy that we think creates more value over the longer term," Brendan Brennan, Chief Financial Officer of ICON, said.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICLR:US $56.43 USD +0.62

ICLR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Charles River Laboratories International Inc $60.77 USD +0.27
Covance Inc $84.45 USD -0.69
PAREXEL International Corp $61.62 USD +0.215
VirtualScopics Inc $5.00 USD 0.00
WuXi PharmaTech Cayman Inc $35.35 USD +0.085
View Industry Companies
 

Industry Analysis

ICLR

Industry Average

Valuation ICLR Industry Range
Price/Earnings 25.5x
Price/Sales 2.5x
Price/Book 3.5x
Price/Cash Flow 18.5x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICON PLC, please visit www.iconplc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.